Victoza Solution For Injection 6Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Victoza: Solution for injection (6mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Victoza 18mg/3ml Pen
Drug Image file default-drug-image.png
Victoza 18mg/3ml Pen

What is this Medicine?

LIRAGLUTIDE (LIR a GLOO tide) is used to improve blood sugar control in adults with type 2 diabetes. This medicine may be used with other oral diabetes medicines.

Similar Brand Name Drugs : Saxenda: Solution for injection (6mg)
CVS Pharmacy Patient Statistics for Victoza: Solution for injection(6mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Victoza 18mg/3ml Pre-Filled Pen Solution for Injection

NDC: 001694060
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Discard 30 days after first use
After initial use, may be stored for 30 days at controlled room temperature (59 to 86 degrees F) or in refrigerator (36 to 46 degrees F)
Store unopened containers in refrigerator (36 to 46 degrees F)
Do not freeze
Discard if product has been frozen
Avoid direct heat and sunlight
Avoid excessive heat (above 104 degrees F)
Victoza 18mg/3ml Pre-Filled Pen Solution for Injection

Reported Side Effects for Victoza 18mg/3ml Pre-Filled Pen Solution for Injection

Rapid Heart Rate Incidence:
<34.0%*
Severity: MODERATE
Onset: EARLY
Skin Redness Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Pancreas Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
High Amylase Levels Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Secondary Malignancy Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Thoughts Of Suicide Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Heart Block Incidence:
0.3%*
Severity: SEVERE
Onset: EARLY
Bundle-branch Block Incidence:
0.3%*
Severity: MODERATE
Onset: EARLY
Cholecystitis Incidence:
0.6%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
0.6%*
Severity: MODERATE
Onset: RAPID
Postural Low Blood Pressure Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
1.1%*
Severity: MODERATE
Onset: RAPID
Gallstones Incidence:
1.5%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
1.6-23.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
2.0-13.9%*
Severity: MILD
Onset: RAPID
Nervousness Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
2.1%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
2.4%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Gas Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
4.3-6.0%*
Severity: MILD
Onset: DELAYED
Belching Incidence:
4.5%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
4.7%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
5.4%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
5.6%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
5.8%*
Severity: MILD
Onset: EARLY
Flu Incidence:
7.4%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
7.5%*
Severity: MILD
Onset: EARLY
Antibody Formation Incidence:
8.6%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
8.7-15.7%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.1%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
9.3-17.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.6%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
9.9-19.4%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
23.9-39.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Victoza 18mg/3ml Pre-Filled Pen Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Victoza 18mg/3ml Pre-Filled Pen Solution for Injection(Liraglutide)
Alcohol and Liraglutide(Liraglutide)
Alcohol may interfere with the actions of Antidiabetic agents (Insulin or other drugs used to treat Diabetes). Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Limit alcohol containing medicines and beverages if you are on Antidiabetic Agents. You should also learn how to recognize the signs of low blood sugar.
Minor Lifestyle Interaction
Tobacco and Victoza 18mg/3ml Pre-Filled Pen Solution for Injection(Liraglutide)
Tobacco and Liraglutide(Liraglutide)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Liraglutide may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Victoza

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.